Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 478-270-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-01-31 to 2007-05-22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study performed according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) and EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) without deviations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Remarks:
- The testing facility indicated that the protocol was followed without deviation.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Remarks:
- The testing facility indicated that the protocol was followed without deviation.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate issued by the Department of Health of the Government of the United Kingdom
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): VRT-753136 hcl
- Molecular formula: not applicable
- Molecular weight: not applicable
- Smiles notation: not applicable
- InChl: not applicable
- Structural formula attached as image file: not applicable
- Substance type: no data
- Physical state: white to off white powder
- Analytical purity: 100 area %
- Impurities: 0.03 area% of unknowns
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: 2006-09-15
- Lot/batch No.: Batch number 25515/Lot No. AF6-001
- Expiration date of the lot/batch: 2008-05
- Stability under test conditions: no data
- Storage condition of test material: room temperature
- Other: no data
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Obtained from Harlan UK Ltd., Bicester, Oxon, England
- Age at study initiation: approximately eight to twelve weeks of age prior to dosing on Day 1
- Weight at study initiation: 18.5 and 21.8 g
- Housing: Animals were housed individually in polycarbonate cages with woodflake bedding.
- Diet: Standard laboratory rodent diet (Special Diet Services RM1 (E) SQC)
- Water: Drinking water was provided ad libitum.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (deg C): 21+/- 2 deg C
- Humidity (%): 40 to 70%
- Air changes (per hr): Not applicable
- Photoperiod (hrs dark / hrs light): Lighting was controlled by means of a time switch to give 12 hours of artificial light (0600 - 1800 hours GMT) in each 24-hour period.
IN-LIFE DATES:
From: 2007-02-01 To: 2007-02-27
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- other: Not applicable
- Vehicle:
- other: Not applicable
- Concentration / amount:
- Not applicable
Challengeopen allclose all
- Route:
- other: Not applicable
- Vehicle:
- other: Not applicable
- Concentration / amount:
- Not applicable
- No. of animals per dose:
- Not applicable
- Details on study design:
- Not applicable
- Challenge controls:
- Not applicable
- Positive control substance(s):
- not required
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Remarks:
- 4:1 v/v
- Concentration:
- 5, 10 and 25% w/v VRT-753136 hcl
- No. of animals per dose:
- Four mice were dosed at three dosage levels, as well as a vehicle control.
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Groups of one female were treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 uL of appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3). The test substance was applied to the dorsal surface of each ear using an automatic micropipette. The test substance was spread over the entire dorsal surface of the ear using the tip of the pipette.
- There were no deaths during the study.
Clinical signs of reaction to treatment comprised:
- Group 1 (5% w/v): Greasy fur around the cranial region was seen post dose from Day 2 and was still present at termination on Day 4.
- Group 2 (10% w/v): Greasy fur around the cranial region was seen post dose from Day 1 and was still present at termination on Day 4. Wet fur cranial region was noted post dose on Day 1 only. In addition, particles on the ears were seen post dose from Day 1 and had resolved by Day 3.
- Group 3 (25% w/v): Greasy fur around the cranial region was seen post dose from Day 1 and was still present at termination on Day 4. In addition, wet fur around the cranial region was noted post dose on Days 1 and 2 only.
- No signs of irritation were seen over the dosed area during the study.
- Bodyweight increases were recorded for all mice over the period of the preliminary study.
- Results indicated that 25% w/v was a suitable high dose level for the main study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: In the main study, the proliferative response of the lymph node cells (LNC) from the draining auricular lymph nodes was assessed five days following the initial application, by measurement of the incorporation of 3H-methyl Thymidine by beta-scintillation counting of LNC suspensions. The response was expressed as radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (test/control ratio).
TREATMENT PREPARATION AND ADMINISTRATION:
- Groups of four mice were treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 uL of the appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3). The test substance was applied to the dorsal surface of each ear using an automatic micropipette. The test substance was spread over the entire dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner.
- A vehicle trial was conducted and identified acetone olive oil (4:1 v/v) as the appropriate vehicle for the main study. This is also the preferred vehicle recommended in the protocol. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- no data
Results and discussion
- Positive control results:
- Responses to the positive control substance hexyl cinnamic aldehyde (HCA), in contemporaneous studies demonstrate the reliability and sensitivity of this assay to detect skin sensitization potential in this laboratory.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In this study, the stimulation indexes (test/control ratio) obtained for 10, 25 or 50% v/v HCA were 7.9, 13.5 and 19.8, respectively. This indicates that HCA showed the potential to induce skin sensitization (delayed contact hypersensitivity) and confirms the sensitivity of the technique to detect skin sensitization.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Group 1 (vehicle control): 4283.65 dpm/2.0 lymph nodes per animal (535.46 dpm/node). Test control ratio: not applicable Result: not applicable Group 2 (5% w/v): 2676.95 dpm/2.0 lymph nodes per animal (334.62 dpm/node) Test control ratio: 0.6 Result: negative Group 3 (10% w/v): 2090.05 dpm/2.0 lymph nodes per animal (261.26 dpm/node) Test control ratio: 0.5 Result: negative Group 4(25% w/v): 2751.85 dpm/2.0 lymph nodes per animal (343.98 dpm/node) Test control ratio: 0.6 Result: negative
Any other information on results incl. tables
Estimation of the Lymph node proliferation response:
- The test/control ratios obtained for 5, 10 and 25% w/v VRT-753136 hcl were 0.6, 0.5 and 0.6, respectively.
- As a test/control ratio of 3 or more was not recorded for any of the concentrations tested, VRT-753136 hcl is not considered to have the potential to cause skin sensitization (delayed contact hypersensitivity).
Main Study
Mortality and clinical signs:
- There were no deaths and no signs of ill health or toxicity observed during this study.
- No signs of irritation were seen over the dosed area during the study.
- Greasy fur was noted for all control and test animals post-dose from Day 1. This sign had resolved completely in all animals in Groups 1, 2 and 3 by Day 5 and was still present in all animals in Group 4 on Day 6 at study termination. Dose residue was seen post dose in one animal in Group 2 from Day 2, and in the remaining animals in Group 2 on Day 3. In addition, dose residue was also seen post dose from Day 1 in some animals from Groups 3 and 4. This sign had resolved by Day 4 in all animals.
Bodyweight:
- Bodyweight increases were recorded for all mice over the period of the main study.
Applicant's summary and conclusion
- Conclusions:
- VRT-753136 hcl is not regarded as a potential skin sensitizer.
- Executive summary:
Not applicable
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.